Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.360
+0.170 (5.33%)
At close: Apr 24, 2025, 4:00 PM
3.350
-0.010 (-0.30%)
Pre-market: Apr 25, 2025, 5:05 AM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 838 employees as of December 31, 2024. The number of employees increased by 281 or 50.45% compared to the previous year.
Employees
838
Change (1Y)
281
Growth (1Y)
50.45%
Revenue / Employee
$195,788
Profits / Employee
-$444,125
Market Cap
1.10B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
IOVA News
- 1 day ago - Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses - GlobeNewsWire
- 6 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Top 3 Health Care Stocks That Are Set To Fly This Month - Benzinga
- 7 weeks ago - Iovance's Q4: Execution Risks Mount As Infusion Growth Slows (Rating Downgrade) - Seeking Alpha
- 2 months ago - Iovance Biotherapeutics, Inc. (IOVA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024 - GlobeNewsWire
- 2 months ago - Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025 - GlobeNewsWire
- 2 months ago - Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer - GlobeNewsWire